Notice2023-07435
Availability of the Draft IRIS Toxicological Review of Perfluorodecanoic Acid [PFDA, CASRN 335-76-2] and Related Salts
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 10, 2023
Issuing agencies
Environmental Protection Agency
Abstract
The Environmental Protection Agency (EPA) is announcing a 60- day public comment period associated with release of the draft IRIS Toxicological Review of Perfluorodecanoic Acid (PFDA, CASRN 335-76-2) and Related Salts. The draft document was prepared by the Center for Public Health and Environmental Assessment (CPHEA) within EPA's Office of Research and Development (ORD). EPA is releasing this draft IRIS assessment for public comment in advance of a contract-led peer review. Public comments received will be provided to the external peer reviewers. ERG, a contractor to EPA, will convene a public meeting to discuss the draft report with the public during Step 4 of the IRIS Process. The external peer reviewers will consider public comments submitted in response to this notice and comments provided at a future public peer review meeting. EPA will consider all comments received when revising the document post-peer review. This draft assessment is not final as described in EPA's information quality guidelines, and it does not represent, and should not be construed to represent Agency policy or views.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 68 (Monday, April 10, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 68 (Monday, April 10, 2023)]
[Notices]
[Pages 21189-21190]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-07435]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-ORD-2019-0287; FRL-10829-01-ORD]
Availability of the Draft IRIS Toxicological Review of
Perfluorodecanoic Acid [PFDA, CASRN 335-76-2] and Related Salts
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice of public comment period.
-----------------------------------------------------------------------
SUMMARY: The Environmental Protection Agency (EPA) is announcing a 60-
day public comment period associated with release of the draft IRIS
Toxicological Review of Perfluorodecanoic Acid (PFDA, CASRN 335-76-2)
and Related Salts. The draft document was prepared by the Center for
Public Health and Environmental Assessment (CPHEA) within EPA's Office
of Research and Development (ORD).
EPA is releasing this draft IRIS assessment for public comment in
advance of a contract-led peer review. Public comments received will be
provided to the external peer reviewers. ERG, a contractor to EPA, will
convene a public meeting to discuss the draft report with the public
during Step 4 of the IRIS Process. The external peer reviewers will
consider public comments submitted in response to this notice and
comments provided at a future public peer review meeting. EPA will
consider all comments received when revising the document post-peer
review. This draft assessment is not final as described in EPA's
information quality guidelines, and it does not represent, and should
not be construed to represent Agency policy or views.
DATES: The 60-day public comment period begins April 10, 2023 and ends
June 9, 2023. Comments must be received on or before June 9, 2023.
ADDRESSES: The IRIS Toxicological Review of Perfluorodecanoic Acid
[PFDA, CASRN 335-76-2] and Related Salts will be available via the
internet on the IRIS website at <a href="https://www.epa.gov/iris/iris-recent-additions">https://www.epa.gov/iris/iris-recent-additions</a> and in the public docket at <a href="http://www.regulations.gov">http://www.regulations.gov</a>,
Docket ID No. EPA-HQ-ORD-2019-0287.
FOR FURTHER INFORMATION CONTACT: For information on the public comment
period, contact the ORD Docket at the EPA Headquarters Docket Center;
telephone: 202-566-1752; facsimile: 202-566-9744; or email:
<a href="/cdn-cgi/l/email-protection#95d1faf6fef0e1cadac7d1d5f0e5f4bbf2fae3"><span class="__cf_email__" data-cfemail="1c58737f77796843534e585c796c7d327b736a">[email protected]</span></a>.
For technical information on the IRIS Toxicological Review of
Perfluorodecanoic Acid (PFDA, CASRN 335-76-2) and Related Salts,
contact Dr. Andrew Kraft, CPHEA; telephone: 202-564-0286; or email:
<a href="/cdn-cgi/l/email-protection#7b10091a1d0f551a151f091e0c3b1e0b1a551c140d"><span class="__cf_email__" data-cfemail="452e372423316b242b21372032052035246b222a33">[email protected]</span></a>. The IRIS Program will provide updates through the
IRIS website (<a href="https://www.epa.gov/iris">https://www.epa.gov/iris</a>) and via EPA's IRIS listserv. To
register for the IRIS listserv, visit the IRIS website (<a href="https://www.epa.gov/iris">https://www.epa.gov/iris</a>) or visit <a href="https://www.epa.gov/iris/forms/staying-connected-integrated-risk-information-system#connect">https://www.epa.gov/iris/forms/staying-connected-integrated-risk-information-system#connect</a>.
For questions about the peer review, please contact: Laurie Waite,
ERG, by email at <a href="/cdn-cgi/l/email-protection#24544141565641524d4153644156430a474b49"><span class="__cf_email__" data-cfemail="06766363747463706f6371466374612865696b">[email protected]</span></a> (subject line: EPA PFAS assessments
peer review); or by phone: (781) 674-7362.
SUPPLEMENTARY INFORMATION:
How To Submit Technical Comments to the Docket at <a href="https://www.regulations.gov">https://www.regulations.gov</a>
Submit your comments, identified by Docket ID No. EPA-HQ-ORD-2019-
0287 for the Perfluorodecanoic Acid IRIS Assessment, by one of the
following methods:
<bullet> <a href="http://www.regulations.gov">www.regulations.gov</a>: Follow the on-line instructions for
submitting comments.
<bullet> Email: <a href="/cdn-cgi/l/email-protection#34705b575f51406b7b6670745144551a535b42"><span class="__cf_email__" data-cfemail="c682a9a5ada3b29989948286a3b6a7e8a1a9b0">[email protected]</span></a>.
<bullet> Fax: 202-566-9744.
<bullet> Mail: U.S. Environmental Protection Agency, EPA Docket
Center (ORD Docket), Mail Code: 28221T, 1200 Pennsylvania Avenue NW,
Washington, DC 20460. The phone number is 202-566-1752.
For information on visiting the EPA Docket Center Public Reading
Room, visit <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>. Due to public health concerns
related to COVID-19, the EPA Docket Center and Reading Room may be
closed to the public with limited exceptions. The telephone number for
the Public Reading Room is 202-566-1744. The public can submit comments
via <a href="http://www.regulations.gov">www.regulations.gov</a> or email.
Instructions: Direct your comments to docket number EPA-HQ-ORD-
2019-0287 for Perfluorodecanoic Acid IRIS Assessment.
Please ensure that your comments are submitted within the specified
comment period. Comments received after the closing date will be marked
``late,'' and may only be considered if time permits. It is EPA's
policy to include all comments it receives in the public docket without
change and to make the comments available online at
<a href="http://www.regulations.gov">www.regulations.gov</a>, including any personal information provided,
unless a comment includes information claimed to be Confidential
Business Information (CBI) or other information for which disclosure is
restricted by statute. Do
[[Page 21190]]
not submit information through <a href="http://www.regulations.gov">www.regulations.gov</a> or email that you
consider to be CBI or otherwise protected. The <a href="http://www.regulations.gov">www.regulations.gov</a>
website is an ``anonymous access'' system, which means EPA will not
know your identity or contact information unless you provide it in the
body of your comment. If you send an email comment directly to EPA
without going through <a href="http://www.regulations.gov">www.regulations.gov</a>, your email address will be
automatically captured and included as part of the comment that is
placed in the public docket and made available on the internet. If you
submit an electronic comment, EPA recommends that you include your name
and other contact information in the body of your comment and with any
disk or CD-ROM you submit. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment. Electronic files should avoid
the use of special characters, any form of encryption, and be free of
any defects or viruses. For additional information about EPA's public
docket visit the EPA Docket Center homepage at <a href="http://www.epa.gov/epahome/dockets.htm">www.epa.gov/epahome/dockets.htm</a>.
Docket: Documents in the docket are listed in the
<a href="http://www.regulations.gov">www.regulations.gov</a> index. Although listed in the index, some
information is not publicly available, e.g., CBI or other information
whose disclosure is restricted by statute. Certain other materials,
such as copyrighted material, are publicly available only in hard copy.
Publicly available docket materials are available either electronically
in <a href="http://www.regulations.gov">www.regulations.gov</a> or in hard copy at the ORD Docket in the EPA
Headquarters Docket Center.
Wayne Cascio,
Director, Center for Public Health & Environmental Assessment.
[FR Doc. 2023-07435 Filed 4-7-23; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 10, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.